Cargando…
Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia
Short-term culture of acute myelogenous leukemia patient's remission lymphocytes with inactivated autologous leukemic blast cells plus allogeneic lymphocytes, generated effector T lymphocytes which were cytotoxic for the specific autologous blast cell in 11 of 14 patients studied. Experiments u...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1978
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184196/ https://www.ncbi.nlm.nih.gov/pubmed/305461 |
Ejemplares similares
-
Restricted autologous lymphocytotoxicity in lung neoplasia.
por: Vose, B. M., et al.
Publicado: (1978) -
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia
por: Tambaro, Francesco Paolo, et al.
Publicado: (2021) -
Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009) -
Celiac disease presented after autologous bone marrow transplantation for acute myelogenous leukemia
por: Valizadeh, Nasim, et al.
Publicado: (2013) -
Immunology: Are complement lysis and lymphocytotoxicity analogous?
por: Lachmann, P.J.
Publicado: (1983)